| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 02/21/2002 | CA2418725A1 Claudin polypeptides |
| 02/21/2002 | CA2418531A1 Therapeutic methods for treating subjects with a recombinant erythropoietin having high activity and reduced side effects |
| 02/21/2002 | CA2418389A1 Pyridine derivatives as inhibitors of p38 |
| 02/21/2002 | CA2418273A1 Urea compounds and methods of uses |
| 02/21/2002 | CA2417846A1 2-aminopyridine compounds and medical use thereof |
| 02/21/2002 | CA2416898A1 Method and composition for altering a b cell mediated pathology |
| 02/21/2002 | CA2416794A1 Method and composition for altering a t cell mediated pathology |
| 02/21/2002 | CA2387002A1 Non-covalent inhibitors of urokinase and blood vessel formation |
| 02/20/2002 | EP1180546A1 Human cell line showing stable expression of cytochromes p450 |
| 02/20/2002 | EP1180518A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 02/20/2002 | EP1180367A1 Intestinal fermentation sulfide deodorizers |
| 02/20/2002 | EP1180355A1 Glass ionomer-based fluoride applying material |
| 02/20/2002 | EP1180152A1 Recombinant bacterial phytases and uses thereof |
| 02/20/2002 | EP1180144A2 Cytoskeleton-associated proteins |
| 02/20/2002 | EP1180143A2 Methods of inducing regulated pancreatic hormone production in non-pancreatic islet tissues |
| 02/20/2002 | EP1180140A1 Variants of traf2 which act as an inhibitor of tnf-alpha signaling pathway |
| 02/20/2002 | EP1180122A1 Structural models for cytoplasmic domains of transmembrane receptors |
| 02/20/2002 | EP1180118A1 Fimbrial proteins |
| 02/20/2002 | EP1180105A2 Substituted aza-oxindole derivatives |
| 02/20/2002 | EP1180101A1 Compounds having cytokine inhibitory activity |
| 02/20/2002 | EP1180028A1 Il-8 receptor antagonists |
| 02/20/2002 | EP1180026A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases |
| 02/20/2002 | EP1180025A1 Il-8 receptor antagonists |
| 02/20/2002 | EP0841922B1 1h-4(5)-substituted imidazole derivatives |
| 02/20/2002 | EP0730447B1 Fatty acid delivery system |
| 02/20/2002 | CN1336926A Carbamate derivatives of diaryl 1,3,4-oxadiazolone |
| 02/20/2002 | CN1336924A Amide and urea derivatives as 5-HT reuptake inhibitors and at 5-HT 1B/1D ligands |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336920A Telmisartan polymorphs, methods for producing same and their use in prepn. of a medicament |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336824A Use of anti-inflammatory steriods for the treatment of chronic iniflammatory intestinal diseases |
| 02/20/2002 | CN1336385A Giant well bombinator proteinase inhibitor and its prepn. and pharmaceutical application |
| 02/20/2002 | CN1336236A Caries resisting immune globulin prepn and its making process |
| 02/20/2002 | CN1336235A Health-care products for regulating immunological function and delaying senility |
| 02/20/2002 | CN1336233A Hepatitis B treating medicine |
| 02/20/2002 | CN1336226A Hepatosis treating traditional Chinese medicine |
| 02/20/2002 | CN1336220A Gastrosis treating Chinese medicine |
| 02/20/2002 | CN1336218A Prepn. of wetness-evil eliminating and dyspepsia relieving medicine tablet |
| 02/20/2002 | CN1336216A Gastrosis treating medicine and its application |
| 02/20/2002 | CN1336207A Life-prolonging tea |
| 02/20/2002 | CN1079397C 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists |
| 02/20/2002 | CN1079263C Caspule for curing chronic enteritis |
| 02/20/2002 | CN1079258C Tablet for treating hepatism |
| 02/19/2002 | USRE37556 Superoxide radical inhibitor |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348497 Prosthetic joints by reducing bone degradation |
| 02/19/2002 | US6348472 NPY antagonists: spiroisoquinolinone derivatives |
| 02/19/2002 | US6348466 CRF receptor antagonists and methods relating thereto |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348458 Polymorphic forms of olanzapine |
| 02/19/2002 | US6348455 Compound for treatment of psychosis |
| 02/19/2002 | US6348452 Microbiocides, bactericides for gastrointestinal disorders in animals |
| 02/19/2002 | US6348447 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348190 Pharmaceutical compositions with antimicrobial activity |
| 02/19/2002 | CA2204604C Processes and intermediates for preparing cis(+)3-[4,-6-dihydroxychroman-3-ylmethyl]-4-methoxyaniline |
| 02/14/2002 | WO2002012556A1 Screening of a novel hepatic syndrome and its uses |
| 02/14/2002 | WO2002012506A1 Lactobacillus rhamnosus polynucleotides, polypeptides and methods for using them |
| 02/14/2002 | WO2002012467A2 Drug metabolizing enzymes |
| 02/14/2002 | WO2002012421A1 Use of essential oils for combating gi tract infection by helicobacter-like organisms |
| 02/14/2002 | WO2002012341A2 Her-2/neu fusion proteins |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012326A2 Mechanism of conditional regulation of the hypoxia-inducible factor-1 by the von hippel-lindau tumor suppressor protein |
| 02/14/2002 | WO2002012286A2 Stress proteins and peptides and methods of use thereof |
| 02/14/2002 | WO2002012249A2 Substituted pyrrole compounds and their use as spla2 inhibitors |
| 02/14/2002 | WO2002012246A1 Pyrrolotriazolopyrimidinone derivatives |
| 02/14/2002 | WO2002012245A2 Azabicyclic derivatives and their therapeutic use |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012225A1 Salts of benzimidazole compound and use thereof |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012207A1 Cyclic oxyguanidine protease inhibitors |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002011742A2 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 02/14/2002 | WO2002011733A1 Pharmaceutical composition comprising condensed indole compound |
| 02/14/2002 | WO2002011725A1 Inflammatory cytokine production inhibitors |
| 02/14/2002 | WO2002011719A2 Lipase inhibitors for the treatment of dyspepsia |
| 02/14/2002 | WO2002011718A1 IgE PRODUCTION INHIBITORS |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO2002011704A2 Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases |
| 02/14/2002 | WO2002011551A2 Oil/fat composition |
| 02/14/2002 | WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 02/14/2002 | WO2001072328A3 Methods of treating diseases with activated protein c |
| 02/14/2002 | WO2001068603A3 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl iv, processes for their preparation, and their use |
| 02/14/2002 | WO2001064247A3 Method of treating cancer with anti-neurotrophin agents |
| 02/14/2002 | WO2001059081A3 Methods for using 20893, a human protein kinase |
| 02/14/2002 | WO2001058922A3 Method and compositions for treating hepatocellular cancer |
| 02/14/2002 | WO2001055119A3 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto |
| 02/14/2002 | WO2001049685A3 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 02/14/2002 | WO2001045725A3 Treatment for inflammatory bowel disease (ibd) and related conditions |
| 02/14/2002 | WO2001044489A3 Galactomannan oligosaccharides and methods for the production and use thereof |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | WO2001014418A3 p193 PROTEINS AND NUCLEIC ACIDS, AND USES THEREOF |
| 02/14/2002 | WO2000059469A9 Endodontic fibers and methods of use therefor |
| 02/14/2002 | WO1995001170A3 Use of phenethanolamine derivatives in the treatment of gastrointestinal disorders |
| 02/14/2002 | US20020019563 A S-(2-(1-iminoethyl)amino)ethyl)-2-methyl-L-cysteine |
| 02/14/2002 | US20020019534 Gem substituted hydroxamic acids |
| 02/14/2002 | US20020019526 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/14/2002 | US20020019515 Novel spoIIIE |